Ann: Agreement Signed for Sale of Lyramid Limited, page-273

Some posts in current threads continue to refer to a company named Roquefort Investments PLC, which hasn’t appeared in any CDY ASX releases.

Reviewing their website does show it to be a good example of a biotech investment company that could be interested in developing one or two of the many possible MK indications available for commercialisation via Lyramid’s licence agreement. Its current stated cash position wouldn’t allow it to be too adventurous at this time.

The graphic below is a cut from slide #20 in the Cellmid November AGM presentation. Negotiations for Lyramid divestment clearly were very well advanced at the time. I think any conspiratorial imaginings posted on HC would need to take into account detail that is revealed there, and in particular the first dot point in section 2.